Longcor Jarrod's most recent trade in Cellectar Biosciences Inc was a trade of 10,000 Warrants done . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 02 Jul 2025 | 10,000 | 10,000 | - | - | Warrants | |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 4.99 per share. | 02 Jul 2025 | 10,000 | 12,768 (0%) | 0% | 5.0 | 49,900 | Common Stock |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 500,000 | 500,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.28 per share. | 10 Jan 2025 | 30,000 | 83,141 (0%) | 0% | 0.3 | 8,400 | Common Stock |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 500,000 | 500,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Longcor Jarrod | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 144,000 | 144,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 42,927 | 53,141 (0%) | 0% | 0 | Common Stock | |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 144,000 | 144,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 475,000 | 475,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 450,000 | 450,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 28 Dec 2020 | 29,630 | 102,148 (1%) | 0% | 1.4 | 40,001 | Common Stock |